These results indicate that CCR9/CCL25 signaling pathway could interact with CD226 signals to activate asthmatic NKT cells, leading to airway hyperresponsiveness and inflammation, aggravating asthma (Sen et al., 2005). This evidence concerns the gene CD226 and asthma.